AOXG (Aoxing Pharmaceutical Co) Research & Development: $2.50 Mil (TTM As of Mar. 2017)


What is Aoxing Pharmaceutical Co Research & Development?

Aoxing Pharmaceutical Co AOXG Research & Development is $2.50 Mil as of Mar. 2017.

Research & Development is the aggregate amount of research and development expenses during the year. Aoxing Pharmaceutical Co's Research & Development for the three months ended in Mar. 2017 was $0.08 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2017 was $2.50 Mil.

Aoxing Pharmaceutical Co  (OTCPK:AOXG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aoxing Pharmaceutical Co Research & Development Related Terms

Aoxing Pharmaceutical Co Research & Development Historical Data

* Premium members only.

The historical data trend for Aoxing Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aoxing Pharmaceutical Co Research & Development Chart

Aoxing Pharmaceutical Co Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 1.48 0.57 0.34 3.14

Aoxing Pharmaceutical Co Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 1.97 0.38 0.08 0.08

Aoxing Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $2.50 Mil mean?
Aoxing Pharmaceutical Co (AOXG) has a Research & Development of $2.50 Mil as of Mar. 2017. Research and development expense is the total cost for research and development activities. View historical data on Aoxing Pharmaceutical Co and its competitors.
Is Aoxing Pharmaceutical Co's Research & Development too high?
Aoxing Pharmaceutical Co's current Research & Development is $2.50 Mil.
How does Aoxing Pharmaceutical Co's Research & Development compare to OWCP and BSPK?
Aoxing Pharmaceutical Co's Research & Development of $2.50 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Diversified Financial Services company?
A good Research & Development depends on the Diversified Financial Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Aoxing Pharmaceutical Co and its competitors. Aoxing Pharmaceutical Co's current Research & Development is $2.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aoxing Pharmaceutical Co stock overvalued right now?
Aoxing Pharmaceutical Co (AOXG) has a current Research & Development of $2.50 Mil. The current Research & Development is $2.50 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Aoxing Pharmaceutical Co (AOXG), the current Research & Development is $2.50 Mil as of Mar. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aoxing Pharmaceutical Co Business Description

Address Block 25, Flat F, 9th Floor, South Horizons, Apleichau, Hong Kong, HKG
Aoxing Pharmaceutical Co Inc does not have any business operations and is restructuring for a new business model and plans to acquire an operating company via reverse merger.